| BRIM-1, -2 and -3 Trials: Improved Survival with Vemurafenib in Metastatic Melanoma Patients with a BRAFV600E Mutation K Young, A Minchom, J Larkin Future oncology 8 (5), 499-507, 2012 | 95 | 2012 |
| Immunotherapy and pancreatic cancer: unique challenges and potential opportunities K Young, DJ Hughes, D Cunningham, N Starling Therapeutic advances in medical oncology 10, 1758835918816281, 2018 | 71 | 2018 |
| Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, AM Schmitt, Z Tippu, ... Cancer Cell 40 (2), 114-116, 2022 | 68 | 2022 |
| Pancreatic neuroendocrine tumors: a review K Young, R Iyer, D Morganstein, I Chau, D Cunningham, N Starling Future Oncology 11 (5), 853-864, 2015 | 50 | 2015 |
| Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours K Young, RT Lawlor, C Ragulan, Y Patil, A Mafficini, S Bersani, ... Gut 70 (10), 1904-1913, 2021 | 46 | 2021 |
| Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy E Kipps, K Young, N Starling Therapeutic advances in medical oncology 9 (3), 159-170, 2017 | 42 | 2017 |
| Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma K Young, E Smyth, I Chau Therapeutic advances in gastroenterology 8 (6), 373-383, 2015 | 33 | 2015 |
| Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, KA Wilkinson, ... Cell Reports Medicine 3 (10), 2022 | 23 | 2022 |
| Targeting deficient DNA damage repair in gastric cancer K Young, N Starling, D Cunningham Expert opinion on pharmacotherapy 17 (13), 1757-1766, 2016 | 23 | 2016 |
| Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways L Spain, A Coulton, I Lobon, A Rowan, D Schnidrig, STC Shepherd, ... Cancer discovery 13 (6), 1364-1385, 2023 | 21 | 2023 |
| Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage P Carotenuto, F Amato, A Lampis, C Rae, S Hedayat, MC Previdi, D Zito, ... Nature Communications 12 (1), 6738, 2021 | 19 | 2021 |
| The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities K Young, N Starling, A Sadanandam Seminars in cancer biology 61, 132-138, 2020 | 19 | 2020 |
| Targeted therapies for advanced oesophagogastric cancer: recent progress and future directions K Young, I Chau Drugs 76 (1), 13-26, 2016 | 16 | 2016 |
| Ipilimumab: showing survival benefit in metastatic melanoma A Minchom, K Young, J Larkin Future Oncology 7 (11), 1255-1264, 2011 | 8 | 2011 |
| The evolving immunotherapeutic landscape in advanced oesophagogastric cancer M Flynn, K Young, D Cunningham, N Starling Therapeutic Advances in Medical Oncology 10, 1758835918786228, 2018 | 7 | 2018 |
